Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

South Korea · Delayed Price · Currency is KRW

2,900.00

-70.00 (-2.36%)

At close: Oct 23, 2026

Vivozon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	174,477	200,675	339,731	144,635	149,085	186,048
Market Cap Growth	-27.99%	-40.93%	134.89%	-2.99%	-19.87%	-37.31%
Enterprise Value	197,245	234,635	367,642	174,909	188,576	192,882
Last Close Price	2900.00	3808.46	6469.68	2821.08	2995.05	5148.47

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	3.47	3.38	3.88	2.03	2.89	3.23
PB Ratio	1.83	2.76	3.19	1.39	1.44	2.15
P/TBV Ratio	1.90	2.91	3.32	1.46	1.52	2.43
P/OCF Ratio	-	-	59.28	48.35	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.92	3.95	4.20	2.45	3.66	3.35
EV/EBITDA Ratio	-	-	208.45	22.04	-	-
EV/EBIT Ratio	-	-	-	37.14	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.35	0.58	0.34	0.40	0.58	0.97
Debt / EBITDA Ratio	-	-	20.70	5.24	-	-
Net Debt / Equity Ratio	0.24	0.51	0.25	0.23	0.33	0.23
Net Debt / EBITDA Ratio	-1.62	-2.52	15.03	3.01	-5.50	-1.43
Net Debt / FCF Ratio	-1.98	-4.49	-9.75	-15.60	-3.45	-0.73
Asset Turnover	0.30	0.34	0.49	0.40	0.27	0.26
Inventory Turnover	1.82	1.98	2.59	3.31	2.21	2.62
Quick Ratio	0.20	0.20	0.31	0.27	0.45	0.87
Current Ratio	0.66	0.43	0.62	0.70	0.60	1.08
Return on Equity (ROE)	-33.67%	-36.10%	-10.13%	-2.13%	-28.26%	-71.69%
Return on Assets (ROA)	-6.97%	-6.85%	-0.63%	1.63%	-3.21%	-5.54%
Return on Capital Employed (ROCE)	-17.20%	-21.80%	-1.60%	4.30%	-9.10%	-18.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-21.41%	-16.16%	-2.94%	-2.32%	-26.77%	-37.33%
FCF Yield	-6.58%	-4.13%	-0.80%	-1.06%	-6.58%	-14.84%
Buyback Yield / Dilution	-8.49%	-3.70%	-0.06%	-9.69%	-33.41%	-24.52%